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Previous studies have shown that blockade of ventral tegmental area (VTA) glutamate
N-Methyl-D-Aspartate (NMDA) receptors induces reward, stimulates forward locomotion
and enhances brain stimulation reward. Glutamate induces two types of excitatory
response on VTA neurons, a fast and short lasting depolarization mediated by
α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors and a longer lasting
depolarization mediated by NMDA receptors. A role for the two glutamate receptors in
modulation of VTA neuronal activity is evidenced by the functional change in AMPA and
NMDA synaptic responses that result from repeated exposure to reward. Since both
receptors contribute to the action of glutamate on VTA neuronal activity, we studied
the effects of VTA AMPA and NMDA receptor blockade on reward induced by electrical
brain stimulation. Experiments were performed on rats trained to self-administer electrical
pulses in the medial posterior mesencephalon. Reward thresholds were measured with
the curve-shift paradigm before and for 2 h after bilateral VTA microinjections of the AMPA
antagonist, NBQX (2,3,-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo(f)quinoxaline-7-sulfonamide,
0, 80, and 800pmol/0.5μl/side) and of a single dose (0.825 nmol/0.5μl/side) of
the NMDA antagonist, PPPA (2R,4S)-4-(3-Phosphonopropyl)-2-piperidinecarboxylic acid).
NBQX produced a dose-dependent increase in reward threshold with no significant change
in maximum rate of responding. Whereas PPPA injected at the same VTA sites produced
a significant time dependent decrease in reward threshold and increase in maximum rate
of responding. We found a negative correlation between the magnitude of the attenuation
effect of NBQX and the enhancement effect of PPPA; moreover, NBQX and PPPA were
most effective when injected, respectively, into the anterior and posterior VTA. These
results suggest that glutamate acts on different receptor sub-types, most likely located on
different VTA neurons, to modulate reward.
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INTRODUCTION
The ventral tegmental area (VTA) contains dopamine neurons
that give rise to the ascending mesocorticolimbic pathway that
plays a key role in motivation and reward. A large body of evi-
dence shows that dopamine neurons are activated by stimuli
that have a positive reinforcing property. Drugs of abuse, for
instance, stimulate dopamine cell firing and/or increase synaptic
dopamine levels in the nucleus accumbens (Wise and Rompré,
1989; Wise, 1996), a limbic region considered as a functional
interface between motivation and action (Mogenson et al., 1980).
Reward induced by electrical brain stimulation also increases
dopamine cell firing and accumbens dopamine release (Moisan
and Rompré, 1998; Hernandez and Shizgal, 2009). But dopamine
neurons do not respond uniquely to appetitive stimuli. Brishoux
et al. (2009) found a sub-group of dopamine neurons that was
activated by footshock. Activation of different dopamine sub-
populations by stimuli that have opposite motivational valence
is likely mediated by different VTA afferent inputs. Ventral mid-
brain neurons are under the control of numerous glutamater-
gic afferents originating from cortical and subcortical limbic
regions (Carr and Sesack, 2000; Geisler et al., 2007; Omelchenko
et al., 2009) and from VTA interneurons (Dobi et al., 2010).
Selective activation of VTA glutamatergic afferent inputs from
the laterodorsal tegmentum nucleus induces conditioned-place
preference while activation of the lateral habenula glutamatergic
inputs produces conditioned-place aversion, opposite motiva-
tional effects that appear to be mediated by activation of the
mesoaccumbens and mesoprefrontal dopamine pathway respec-
tively (Lammel et al., 2012). The rewarding value of a stimulus is
signaled when firing of dopamine neurons shifts from a tonic to a
phasic mode, and this mode of firing is associated with enhanced
dopamine release (Gonon, 1988; Schultz, 2007). The induction
of burst firing pattern of dopamine neurons is under the con-
trol of glutamatergic afferents from the laterodorsal tegmental
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nucleus (Lodge and Grace, 2006). Consistently, Lammel et al.
(2012) showed that activation of mesoaccumbens dopamine neu-
rons by laterodorsal tegmental afferents was blocked by the
AMPA antagonist, CNQX, and the conditioned-placed prefer-
ence prevented by blockade of accumbens D1/D2- like dopamine
receptors. But the modulatory role of glutamate is not limited
to dopamine neurons. Glutamatergic terminals from efferent
neurons of different limbic nuclei and from local interneurons
establish synaptic connections with non-dopamine neurons (Carr
and Sesack, 2000; Omelchenko et al., 2009; Dobi et al., 2010).
Among these non-dopamine neurons are GABAergic neurons
that exert a negative modulation on dopamine activity (Grace
et al., 2007). Selective activation of lateral habenula glutamater-
gic pathway induces excitatory post-synaptic currents (EPSCs)
in GABAergic neurons located in the rostromedial tegmental
nucleus also named the tailed of VTA (RMtg/tVTA; Lammel
et al., 2012). These neurons send an inhibitory input to more
rostral VTA dopamine neurons and this signal is triggered by
aversive stimuli (see Bourdy and Barrot, 2012). It appears then
that glutamate can generate opposite motivational effects by act-
ing either on different VTA dopamine and/or GABA neurons.
It is not clear at this point whether these different motiva-
tional effects are mediated by different glutamatergic receptors.
Both activation and blockade of VTA NMDA receptors increases
accumbens dopamine release (French et al., 1993; Karreman
et al., 1996; Mathe et al., 1998; Kretschmer, 1999) and stim-
ulates forward locomotion (Kretschmer, 1999; Cornish et al.,
2001). Mice (David et al., 1998) and rats (Webb et al., 2012)
can be trained to self-administer the NMDA antagonists, AP-5
and AP-7, into the VTA, suggesting that a positive motiva-
tional valence predominates following blockade of the receptors.
Consistently, Bergeron and Rompré (2013) found that block-
ade of VTA NMDA receptors enhances brain stimulation reward
and operant responding, effects that are mostly likely mediated
by NMDA receptors that are devoid of GluN2b subunits. Less
is known about the role of VTA AMPA receptors in reward.
Activation of VTA AMPA receptors stimulates dopamine impulse
flow and accumbens dopamine release (Chergui et al., 1993;
Karreman et al., 1996). But blockade of VTA AMPA receptors
stimulates locomotor activity, increases operant responding for
conditioned reinforcement and induces conditioned-place pref-
erence, behaviors that reflect of a positive motivational effect
(Harris and Aston-Jones, 2003; Harris et al., 2004; Nolan et al.,
2010).
To further clarify the role of VTA AMPA receptors in reward,
we investigated the effects of VTA microinjections of the AMPA
antagonist, NBQX, on reward and operant responding induced
by electrical brain stimulation. We also tested the effects of PPPA,
a NMDA antagonist, to determine whether blockade of each
receptor sub-type independently at the same VTA sites produces
similar effects.
EXPERIMENTAL PROCEDURES
ANIMALS
Male Long-Evans rats (Charles River Canada) weighting between
300 and 350 g at the time of surgery were used. They were housed
2 per cage (1 per cage after surgery) in a temperature (22◦C)
and humidity (40%) controlled room with a 12 h light/dark cycle
(lights on at 06:00). They were allowed to habituate for 7 days
to the housing environment before surgery and had free access
to food and water. All procedures were in accordance with the
guidelines of the Canadian Council on Animal Care and all efforts
were made to minimize suffering and the number of animals
used.
SURGERY
Rats were anaesthetized with isoflurane (2.5–3.5%, O2 0.7 L/min)
and placed on a stereotaxic apparatus. The surface of the skull
was exposed between lambda and bregma and burr holes were
made into the cranium at the point of insertion of the stim-
ulation electrode and the guide cannulae. A moveable stimula-
tion electrode (Miliaressis, 1981) made from a 0.27mm stainless
steel wire insulated with epoxy (except for the round tip) was
implanted into the postero-medial mesencephalon using the fol-
lowing flat skull coordinates: 7.6mmposterior to bregma, 0.0mm
lateral to the midline and 6.8mm below the surface of the skull
(Paxinos and Watson, 1986). Because electrical stimulation of
this area activates reward-relevant axons that travel bilaterally
through the VTA (Boye and Rompré, 1996), a guide cannula
(HRS Scientific, Montreal, Canada, model C315G) was implanted
in each hemisphere; coordinates were 5.4–5.6mm posterior to
bregma, 3.2mm lateral to the midline (18◦ medio-lateral angle)
and 6.4mm below the surface of the skull; each cannula was
closed with an obturator of the same length. A bare wire con-
nected to a male Amphenol connector was wrapped around
four stainless steel screws that were threaded into the skull; it
served as the inactive electrode. The cannula/electrode assem-
bly was anchored to the skull with dental acrylic. A 0.05mL
injection of Duplocillin LA containing 15,000 I.U. of peni-
cillin was administered (im) to prevent infections. The anal-
gesic Anaphen (5mg/kg, sc) was administered at the end of
surgery.
BEHAVIORAL TRAINING
Five to seven days after surgery, rats were placed in a test cage
(25 × 25 cm) made from polymer walls and one front Plexiglas
wall that allowed observation. To reduce disturbance from exter-
nal noise, test cages were encased in ventilated melamine boxes.
Each test cage was equipped with an infrared photocell inside a
hole (3 cm diameter and 3 cm deep) located 2 cm above the wire-
mesh floor. Interruption of the photocell triggered a constant-
current pulse generator (Mundl, 1980) that delivered a single
400ms train of 0.1ms cathodal rectangular pulses. Each train
was followed by a period of 600ms during which the pulse
generator could not be triggered (see Bergeron and Rompré,
2013). Using the standard shaping procedure, rats were trained
to produce a nose poke to receive a train of stimulation; the
current and the frequency were varied until the rat learned
the task. If a rat did not learn to respond, the electrode was
lowered by 0.2 or 0.4mm and a new site was tested; the elec-
trode was lowered this way until the rat learned to respond
regularly. Following this period of shaping, rats were trained
to respond during discrete 55-s trials, each being followed by
an interval of 15-s during which stimulation was not available.
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The beginning of each trial was signaled by 5 trains of non-
contingent priming stimulation delivered at a rate of 1 per second.
With the current intensity held constant, the frequency (num-
ber of pulses per train * 2.5) was varied from 100 to 30Hz
in 0.06–0.09 log unit steps; this generated a curve relating the
number of nose-pokes per trial to the stimulation frequency
(rate/frequency or R/F curve). An index of reward threshold was
inferred from each R/F curve and it was defined as the pulse
frequency sustaining a half-maximal rate of responding (M50).
The current intensity was set for each rat to generate a M50
value between 60 and 70Hz. During the training phase, four R/F
curves were determined during consecutive daily test sessions.
Testing began when the lower and higher M50 values derived
from the last three R/F curves varied by less than 0.1 log unit for
3 days.
DRUG AND VEHICLE TESTS
A first saline test was carried out to habituate the animals
to the injection procedure. This test was similar to the sub-
sequent drug and vehicle tests and consisted of determining
four R/F curves before and seven curves after the injections.
Bilateral injections were made by inserting into each guide can-
nula an injection cannula (model C315I) that extended 2mm
beyond the tip of the guide. Each injection cannula was con-
nected with polyethylene tubing to a 2-μl microsyringe and
a 0.5μl volume of sterile 0.9% saline was injected into each
hemisphere simultaneously with a micro-infusion pump over a
period of 60 s; the injection cannulae were left in place for an
additional 60 s to allow diffusion into the tissue. Results from
this test were not included in the analysis. Drug and vehicle
tests began at least 5 days after this first habituation test. On
a test day, four baseline R/F curves were first determined over
a period of 70min; the first one was considered as a warm-
up and discarded. Then each rat was centrally injected with
the drug, or its vehicle, using the procedure described above
and seven additional R/F curves were determined over a test
session that lasted approximately 125min, starting immediately
after the injection. Rats were initially tested with one of two
doses of NBQX [80 (30 ng) and 800 (300 ng) pmol/0.5μl/side],
or the vehicle; they received all doses (including vehicle) in
a counterbalanced order. These doses were based on previous
studies (Nolan et al., 2010; Waraczynski et al., 2012) and on
preliminary data from our lab. Following completion of the
NBQX tests, we tested the effect of a single dose of the NMDA
antagonist, PPPA, (0.825 nmol/0.5μl/side), that was previously
reported to alter reward (Bergeron and Rompré, 2013). There
were at least 7 days between two consecutive drug or vehicle
tests.
DATA ANALYSIS
The mean changes in M50 (reward threshold) and maximal rate
of responding (maximal rate of nose poke from each R/F curve)
were expressed as the percentage of pre-injection value (baseline)
and group means were calculated for each dose and vehicle result.
Mean percentage change of both M50 and maximum response
were analyzed with a Two-Way (dose × time) analysis of vari-
ance (ANOVA) for repeated measures. Homogeneity of variance
was tested and square root or log data transformations were per-
formed or Greenhouse-Geiser correction of degrees of freedom
used when necessary. Comparisons among means were made
with the Holm-Sidak test with the level of significance set at 0.05
(SigmaStat, V11.0, Systat Software Inc.; IBM SPSS Version 20).
HISTOLOGY
At the end of the experiment, the animals were deeply
anesthetized with urethane (1.4–2.0 g/kg, i-p.) and the stimula-
tion and injection sites were marked by passing an anodal current
of 0.1mA during 60 s through the electrode and the two injec-
tion cannulae that were inserted into the guides. The animals
were then perfused with 0.9% saline followed by a 10% for-
malin solution and the brains were extracted and soaked in a
solution containing 3% potassium ferrocyanide, 3% potassium
ferricyanide and 0.5% trichloroacetic acid for 24 h. The brains
were then rinsed and stored in a 10% formalin solution for sev-
eral days. They were subsequently frozen and sliced in 40μm
sections that were mounted on gelatin-coated glass slides. The
location of the stimulation and of the injections sites were deter-
mined under light microscopy from freshly sliced sections and/or
sections stained with Nissl’s technique. Animals that had both
injection sites within the VTA, including the rostral and caudal
linear nuclei, the paranigral, parabrachial and the interfascicu-
lar nuclei, and the medial part of the substantia nigra between
4.8 and 6.0mm behind bregma (Paxinos and Watson, 1986) were
included in the analyses.
DRUGS
NBQX disodium (2,3,-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo(f)
quinoxaline-7-sulfonamide disodium), and PPPA [(2R, 4S)-
4-(3-Phosphopropyl)-2-piperidinecarboxylic acid], were pur-
chased from Tocris Bioscience (Ellisville, MI, USA). They
were dissolved in sterile 0.9% saline and stored frozen
in 20μl aliquots. Drug solutions were thawed and diluted
when necessary just prior to testing. Doses are expressed
as salt.
RESULTS
Of the 12 animals initially prepared for the study, 8 were success-
fully trained and completed the experiment. Histological anal-
ysis revealed that the stimulation sites were located within the
postero-medial mesencephalon, within the ventral central gray,
between the anterior-posterior regions corresponding to 7.3 and
7.8mm posterior to bregma (Figure 1, right panels). The injec-
tion sites for the eight animals included in the analyses are shown
in the left panels of Figure 1. Sites were located between 5.0 and
5.8mm posterior to bregma, within the ventral part of the VTA,
a region that contains neurons activated by rewarding electri-
cal stimulation (Moisan and Rompré, 1998; Marcangione and
Rompré, 2008).
NBQX ATTENUATED BRAIN STIMULATION REWARD
Rate-frequency curves obtained from rat SB197 after bilateral
VTA injections of vehicle, 80 and 800 pmol/0.5μl/side of NBQX
are shown in Figure 2. NBQX produced a dose-dependent right-
ward shift of the R/F curve reflecting a reduction of the rewarding
effectiveness of the stimulation; the larger shift was produced
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FIGURE 1 | Location of injection (left panels) and stimulation (right
panels) sites for each animal included in the study. Each site is
represented by a single cross. Illustrations are modified drawings from
Paxinos and Watson’s atlas (1986); the number on the side of each plate
represents the anterior-posterior distance (mm) from bregma.
by the high dose. This attenuation of reward was not evident
following injections of the vehicle (top panel). Figure 3 shows
mean changes (expressed in % of baseline) in reward thresh-
old (top panels) and maximal response (bottom panels) for each
dose of NBQX. The magnitude of the increase in reward thresh-
old produced by NBQX varied with the dose but not the time
post-injection. Analysis of variance yielded a significant effect
of treatment [F(2, 21) = 4.92, p < 0.05] but no treatment by
time interaction [F(12, 126) = 1.32, p > 0.05]. Post-hoc test con-
firmed that the increase in threshold measured after injection
of 800 pmol of NBQX is significantly different than that mea-
sured after vehicle; there is no significant difference between
vehicle and 80 pmol. Maximum rate of responding was not
significantly altered by NBQX (bottom panel). Analysis of vari-
ance yielded no significant effect of treatment [F(2, 21) = 0.97,
p > 0.05] and no treatment by time interaction [F(4.755, 49.923) =
1.31, p > 0.05], suggesting that the increase in reward threshold
results from a selective reduction in the rewarding effectiveness of
the stimulation.
PPPA ENHANCED BRAIN STIMULATION REWARD
Since AMPA and NMDA receptors can be functionally linked
and that both are involved in the modulation of VTA neurons
by glutamate, we tested the effect of PPPA, a NMDA antago-
nist, injected at the same sites in every animal that was tested
with NBQX. The dose of PPPA used was found previously to
enhance reward when injected into the VTA (Bergeron and
Rompré, 2013). Figure 4 illustrates the R/F curves obtained from
the same rat, SB197, after bilateral VTA injections of PPPA (bot-
tom panel). PPPA produced initially a small rightward shift of
R/F curve that was followed by a shift to the left; the magnitude
of the leftward shifts induced by the vehicle was smaller, sug-
gesting that in this rat PPPA slightly enhanced reward. Grouped
FIGURE 2 | Rate-frequency curves obtained from rat SB197 prior to
(baseline) and after injection of vehicle (top panel, 0 nmol) and two
doses (80 and 800pmol/0.5 µl/side, middle and bottom panels
respectively) of NBQX. For clarity only four curves, including averaged
baseline curves, are shown. The x-axis represents the number of pulses
per train on a log scale.
means from the eight animals tested confirmed the enhancement
effect of PPPA (Figure 5, top panels). The ANOVA performed
on mean changes in reward threshold yielded a significant effect
of treatment [F(1, 14) = 8.68, P < 0.05] and a significant treat-
ment by time interaction [F(6, 84) = 6.45, p < 0.001]. Post-hoc
test showed that PPPA significantly reduced threshold compared
to vehicle during the first 54min post-injection (top, left panel).
Unlike NBQX, PPPA produced a significant change in maxi-
mum response (bottom panels). The ANOVA yielded a significant
effect of treatment [F(1, 14) = 9.5, p < 0.002] and a significant
treatment by time interaction [F(6, 84) = 2.8, p < 0.02]. Post-hoc
test showed that the maximum response was enhanced com-
pared to vehicle between 54 and 90min post-injection. It is
interesting to notice the discrepancy between the time course
of the effect of PPPA on reward threshold and on maximum
response.
INVERSE RELATIONSHIP BETWEEN THE ATTENUATION
EFFECT OF NBQX AND THE ENHANCEMENT EFFECT OF PPPA
ON REWARD: A SITE DEPENDENT EFFECT
In order to determine whether the opposite effects of NBQX and
PPPA on reward was related to the site of injection within the
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FIGURE 3 | Changes in reward threshold (top panels) and
maximum response (bottom panels) as a function of time (left
panels) after injection of vehicle (VEH) and each of the two
doses of NBQX. Data represent the mean (±sem) from eight animals
and are expressed as percentage of baseline on a log scale. Changes
(mean ± sem) measured over the entire test session are shown in
the right panels. Asterisk indicates a statistically significant difference
(p < 0.05) with VEH.
VTA, we first correlate the changes in reward threshold produced
by each drug. The correlation was calculated from the average
percent change in reward threshold of the first three measures
(between 20 and 54min), a time at which PPPA and NBQX pro-
duced significant behavioral effects; they were transformed in
absolute log unit deviation from baseline. Scatter plot presented
in Figure 6 (top panel) shows that the magnitude of the atten-
uation effect of NBQX on reward was inversely related to the
magnitude of the reward enhancement produced by PPPA. This
inverse relationship seems to be due to the site of injection over
the antero-posterior axis. In effect, the effectiveness of NBQX
at attenuating reward is inversely related to the VTA antero-
posterior level, being most effective in the anterior VTA (middle
panel). The opposite was found with PPPA, and the more poste-
rior was the injection the larger the reward enhancement (bottom
panel).
DISCUSSION
A major finding of this study is that blockade of VTA AMPA
receptors following in situ microinjections of NBQX, a selective
AMPA receptor antagonist (Sheardown et al., 1990), attenu-
ated in a dose-dependent manner reward induced by electrical
stimulation of the medial posterior mesencephalon. The reward
attenuation reflected by a rightward-shift of the R/F curve was
not accompanied by a significant change in maximum rate of
FIGURE 4 | Rate-frequency curves obtained from rat SB197 prior to
(baseline) and injection of vehicle (top panel, 0 nmol) and PPPA
(0.825nmol/0.5 µl/side). For clarity only four curves, including averaged
baseline curves, are shown. The x-axis represents the number of pulses
per train on a log scale.
FIGURE 5 | Changes in reward threshold (top panels) and maximum
response (bottom panels) as a function of time (left panels) after
injection of vehicle (VEH) and PPPA (0.825nmol/0.5 µl/side). Data
represent mean (±sem) from eight animals and are expressed as
percentage of baseline on a log scale. Changes (mean ± sem) measured
over the entire test session are shown in the right panels. Asterisk indicates
a significant difference (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001) with VEH.
responding. This selective displacement of the R/F curve on the
stimulation frequency axis demonstrates that NBQX produced a
specific attenuation of the reward signal initiated by the electrical
stimulation (Miliaressis et al., 1986).
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FIGURE 6 | The top panel shows a scatter plot illustrating the log
percent change (from baseline) in reward threshold measured for each
rat after injection of 0.825nmol of PPPA (x-axis) and 800pmol of NBQX
(y-axis). Scatter plots illustrating the log percent change (from baseline) in
reward threshold measured for each rat after injection of 0.825 nmol of
PPPA and 800pmol of NBQX as a function of the location of the injections
sites along the antero-posterior axis of the brain are shown in the middle
and bottom panels respectively. Correlation index (R) and level of
significance are shown along with the linear regression line (plain line) and
the 95% confidence interval (dotted lines) in each plot. See text for details.
The most likely hypothesis to account for the attenuation
effect of NBQX is a reduction in glutamatergic excitatory inputs
to dopamine neurons. Rewarding electrical stimulation increases
dopamine cell firing and accumbens dopamine release (Moisan
and Rompré, 1998; Hernandez and Shizgal, 2009). Specific
reward attenuations are observed following systemic injection
of low doses of the dopamine receptor antagonist, haloperi-
dol (Benaliouad et al., 2007). Ventral midbrain microinjec-
tions of drugs known to increase and block dopamine impulse
flow enhance and attenuate brain stimulation reward respec-
tively (Rompré and Wise, 1989a,b; Wise and Rompré, 1989).
Accumbens dopamine release induced by a cue associated with
brain stimulation reward is blocked by a VTA microinjection of
lidocaine, suggesting that it is mediated by synaptic activation of
VTA neurons (Sombers et al., 2009). Glutamate containing ter-
minals establish synaptic contacts with dopamine neurons (Carr
and Sesack, 2000; Omelchenko et al., 2009) and brain stimu-
lation reward is associated with an increase in VTA glutamate
release an effect that is prevented by infusion of tetrodotoxin (You
et al., 2001). Activation of glutamatergic efferents to dopamine
neurons produces AMPA mediated EPSCs, increases dopamine
cell firing and induces conditioned-place preference (Lammel
et al., 2012). It thus appears likely that NBQX attenuated the
reward signal initiated by posterior mesencephalic electrical stim-
ulation, a signal carried by glutamatergic inputs to dopamine
neurons. This hypothesis is rather inconsistent with previous
findings showing that blockade of VTA AMPA receptors stim-
ulates spontaneous motor activity and induces a conditioned-
place preference (Harris and Aston-Jones, 2003; Harris et al.,
2004; Nolan et al., 2010). It was also shown, however, that
VTA microinjection of CNQX, an AMPA antagonist, also pre-
vents morphine-induced increase in dopamine cell firing and
morphine-induced conditioned-place preference (Harris et al.,
2004; Jalabert et al., 2011). The valence of the motivational
effect of AMPA receptor blockade may depend upon the level
of activity of the dopamine system. Morphine, like brain stim-
ulation reward, stimulates dopamine impulse flow and release
and under such a condition of high dopamine activity block-
ade of AMPA receptors may reduce the positive reinforcing
effect.
Electrophysiological studies have shown that activation of
dopamine neurons by glutamate is also mediated by NMDA
receptors. Electrical stimulation of VTA afferents to dopamine
neurons, for instance, produces NMDA mediated EPSCs (see
Ungless et al., 2001) and NMDA produces a dose-dependent
increase dopamine cell firing (Seutin et al., 1990; Wang and
French, 1993). Deletion of NMDA receptor from dopamine
neurons abolishes burst firing, a mode of activity that is asso-
ciated with enhanced dopamine release and reward (Gonon,
1988; Schultz, 2007; Zweifel et al., 2009). On the basis of
these findings, microinjections of the selective NMDA antago-
nist, PPPA, was expected to attenuate reward. However, PPPA
produced an enhancement rather than an attenuation of the
reward signal initiated by posterior mesencephalic electrical
stimulation. The reward enhancement was unrelated to the
increase in maximum rate of responding since these PPPA
effects occurred over a different time course. The effects of
PPPA are very similar to those reported previously with the
same dose by Bergeron and Rompré (2013). To explain this
unexpected enhancement of reward and operant responding,
Bergeron and Rompré proposed that PPPA acted on NMDA
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receptors that were mainly composed of GluN2A sub-units and
that these NMDA receptors were expressed on non-dopamine
neurons. There is no direct evidence that dopamine neurons
expressed NMDA receptors that are devoid of GluN2A recep-
tors. However, GluN2A subunits are present in the VTA and
some electrophysiological data suggest that they are expressed
by non-dopamine neurons (Jones and Gibb, 2005; Suarez et al.,
2010).
It is well established that exposure to drug reward induces
synaptic plasticity at glutamatergic synaptic inputs to dopamine
neurons; this plasticity is characterized by enhanced AMPA
EPSCs, due to replacement of GluR2 sub-units for the more con-
ductive GluR1 sub-units, and by reduced NMDA EPSCs (Ungless
et al., 2001). Following these synaptic changes, the contribu-
tion of AMPA receptor to activation of dopamine neurons is
stronger than that of NMDA and under this condition it is
expected that blockade of AMPA receptors has a larger impact
than blockade of NMDA receptors on the excitatory signal to
dopamine neurons. That could explain why NBQX but not PPPA
attenuated reward. For this hypothesis to be right, however,
one has to postulate that brain stimulation reward induces an
increase in AMPA/NMDA EPSC ratio at glutamatergic synapses
on dopamine neurons. This might be the case as Boye et al.
(2007) have shown that training for brain stimulation reward
sensitizes to amphetamine induced forward locomotion, a sensi-
tization effect that is associated with an enhanced AMPA/NMDA
ratio (Saal et al., 2003). Carlezon et al. (2001), however, reported
a reduction in VTA AMPA receptor sub-unit, GluR1, in ani-
mals that were trained to respond for brain stimulation reward,
a finding inconsistent with an increase in AMPA/NMDA EPSC
ratio.
A large amount of non-dopamine neurons are GABAergic
neurons that provide a tonic inhibitory input to dopamine (Grace
et al., 2007). Glutamatergic terminals establish synaptic con-
tacts with non-dopamine neurons (Omelchenko et al., 2009) and
these are stimulated by activation of NMDA receptors (Wang
and French, 1995). It could be then that PPPA enhanced reward
by removing the tonic GABAergic inhibition to dopamine neu-
rons, as proposed by Bergeron and Rompré (2013). Since the
activity of VTA non-dopamine neurons is also stimulated by acti-
vation of AMPA receptors (Wang and French, 1995), it is not
clear why NBQX did not produce effects that were similar to
those of PPPA. A hypothesis that may reconcile the opposite
effects is that NBQX and PPPA acted on different sub-populations
of VTA neurons. Our correlation analyses tend to support this
hypothesis. First we found that the magnitude of the reward
attenuation effect of NBQX was inversely related to the magni-
tude of the reward enhancing effect of PPPA. This means that at
sites where NBQX produced the larger reward attenuations, PPPA
produced the smallest reward enhancements. A second analy-
sis revealed opposite correlations between the anterior-posterior
VTA level and the absolute change in reward produced by each
antagonist. NBQX was most effective when injected in the ante-
rior VTA while PPPA was most effective when injected in the
posterior VTA. GABAergic neurons in the RMtg/tVTA receive a
dense glutamatergic innervation from the lateral habenula and
these provide an inhibitory input to VTA dopamine neurons
(Brinschwitz et al., 2010). Selective activation of lateral habenula
glutamatergic pathway induces EPSCs in RMtg/tVTA GABAergic
neurons and induced conditioned-place aversion (Lammel et al.,
2012). Dopamine cell firing is, respectively, reduced and enhanced
by activation and inhibition of RMtg/tVTA neurons (Bourdy
and Barrot, 2012). Rats self-administer NMDA antagonists into
the VTA and the most effective sites are within or near the
RMtg/tVTA (David et al., 1998; Webb et al., 2012). It is possi-
ble that PPPA enhanced reward by blocking some glutamatergic
inputs to RMtg/tVTA neurons. Again, the reason why NBQX was
not as effective as PPPA is unclear, particularly because EPSCs
induced in RMtg/tVTA neurons by stimulation of glutamatergic
inputs are mediated, at least in part, by AMPA receptors (Lecca
et al., 2011). It could be that PPPA enhanced reward by acting
on RMtg/tVTA and on other VTA neurons since it is still effec-
tive when injected in more VTA anterior sites; this conclusion
was proposed by Bergeron and Rompré (2013) on the bases of
the results that they obtained with another NMDA antagonist,
R-CPP.
Shabat-Simon et al. (2008) have shown that the reward-
ing effect of opiates as measured with the conditioned-place
preference and self-administration paradigms is prevented by
blockade of VTA AMPA receptors. Interestingly, they showed
that CNQX was most and least effective when injected, respec-
tively, into the anterior and posterior VTA. These findings par-
allel the results that we obtained in the present study with
NBQX.
Another observation suggesting that NBQX and PPPA acted
on different sub-population of VTA neurons to alter brain stim-
ulation reward is that PPPA, but not NBQX, produced a sig-
nificant increase in maximum rate of responding. The fact that
the enhancement of reward and operant responding occurred
over a different time course suggests that they are mediated by
the action of PPPA on different substrates. A similar dissocia-
tion between changes in reward and operant responding has been
reported previously with different pharmacological treatments
(Rompré, 1995; Boye and Rompré, 2000; Benaliouad et al., 2009;
Gallo et al., 2010). That reinforces the hypothesis that some VTA
neurons are more sensitive to NMDA than AMPA receptor block-
ade and vice versa. Investigation of NMDA and AMPA synaptic
responses on different VTA neuron sub-populations in animals
previously trained for brain stimulation reward may provide
important insights into the identification of the neural substrates
of reward.
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